We are excited about working with NADII scientists to adapt ERA-CODE(TM) technology to meet the high standards Novartis is setting for genotyping.
NADII is one of the largest single research endeavors dedicated to agricultural genomics research and development.
amp;uot;The agreement with NADII
is a further validation of the utility of our technology&uot; said Andrew Baum, SemBioSys' President and Chief Executive Officer.
We are pleased to offer this powerful new product to all of our customers engaged in agriculture research, through a fruitful collaboration with NADII
, a clear leader in the field," commented Susan E.